Related Experiment Video
Updated: Sep 26, 2025

03:13
Author Spotlight: A Single-Entry Point Endoscopic Intraventricular Approach for Third Ventriculostomy and Pineal Biopsy
Published on: June 28, 2024
845
Primary Intraosseous Osteolytic Meningioma with Aggressive Clinical Behaviour: Clinico-Pathologic Correlation and
Nazmin Ahmed1, Gianluca Ferini2, Moududul Haque3
1Department of Neurosurgery, Ibrahim Cardiac Hospital and Research Institute (A Centre for Cardiovascular, Neuroscience and Organ Transplant Units), Shahbag, Dhaka 1000, Bangladesh.
Life (Basel, Switzerland)
|April 23, 2022
Summary
Primary intraosseous osteolytic meningiomas (PIOM) are rare tumors. Surgical resection, particularly gross total removal (GTR), is the recommended treatment for PIOM, offering high success rates and low complication risks.
Area of Science:
- Neurosurgery
- Oncology
- Pathology
Background:
- Primary intraosseous osteolytic meningiomas (PIOM) are a subset of primary extradural meningiomas (PEM).
- These tumors are characterized by an osteolytic component, sometimes with hyperostotic reactions, and are not dural-based.
- Previous classification systems have limitations, necessitating a new approach.
Purpose of the Study:
- To present a unique case of PIOM.
- To conduct a systematic literature review of PIOM cases.
- To propose a novel classification system for PIOM.
Main Methods:
- Systematic literature search of Google Scholar, PubMed, and Scopus databases up to December 2020.
- Inclusion of case studies on PIOM, adhering to PRISMA guidelines.
- Analysis of a new case of PIOM in a 46-year-old female patient.
Main Results:
- A total of 55 PIOM cases (including the presented case) were analyzed.
- The most common location was the frontal and parietal calvarium (29.1% frontal bone).
- Surgical resection (87.3%) with Gross Total Resection (GTR) achieved in 80% of cases was the primary treatment, with low recurrence rates (7.3%).
Conclusions:
- Surgical resection, especially GTR, is the treatment of choice for PIOM.
- PIOMs have a high GTR rate and low risk of complications and mortality.
- Further research is needed for differential diagnosis and specific PIOM treatments.

